Anixa Biosciences share price logo

Anixa Biosciences

NASDAQ: ANIX

$2.95

+0.18

(+6.50%)

as on

Anixa Biosciences Stock Performance

as on October 3, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.77
    $2.93
    downward going graph

    6.10%

    Downside

    -0.68%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.32
    $5.46
    downward going graph

    21.36%

    Downside

    84.97%

    Upside

    downward going graph

Anixa Biosciences share price movements today

Previous Close
$2.77
Open
$2.79
Volume
577.8K
Market Cap
$96.3M
Day's Low - High
$2.77 - $2.93
52 Week Low - High
$2.32 - $5.46

Anixa Biosciences Historical Returns

1 Month Return
-3.28 %
3 Month Return
-9.79 %
1 Year Return
-9.79 %
3 Year Return
-3.28 %
5 Year Return
-37.89 %

Anixa Biosciences Stock Fundamentals & Key Indicators

Check Anixa Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$96.3M

EPS (TTM)

-0.305

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-9.1

Industry PE ratio

-3.02

PEG Ratio

0.01

EBITDA

-10.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-70.44%

Anixa Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anixa Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$96.3M-37.89%-9.100.00%0.00%
StrongBuy$44.1B609.62%-23.340.00%0.00%
Neutral$75.4B-44.29%-24.08-12.57%0.00%
StrongBuy$132.5B180.98%30.1986.04%0.00%
Buy$78.1B28.80%17.6784.86%0.50%

Stock Returns calculator for Anixa Biosciences Stock including INR - Dollar returns

The Anixa Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Anixa Biosciences investment value today

Current value as on today

₹97,905

Returns

-₹2,095

(-2.09%)

Returns from Anixa Biosciences Stock

-₹9,786 (-9.79%)

Dollar Impact

₹7,691 (+7.69%)

Analyst Recommendation on Anixa Biosciences Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Anixa Biosciences. Average target price of $9.75

Anixa Biosciences Share Price Target

Get share price movements and forecasts by analysts on Anixa Biosciences.

What analysts predicted

69.74%UPSIDE

Target Price

$9.75

Current Price

$2.95

Analyzed by

7 Analysts

Target

$9.75

Anixa Biosciences target price $9.75, a slight upside of 69.74% compared to current price of $2.95. According to 7 analysts rating.

Indian Investors' Interest in Anixa Biosciences Stock

Search interest for Anixa Biosciences Stock has increased by 112% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:112% versus previous 30 day period

Anixa Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
0
-
-
0
Operating Income
-3
-3
-3
-3
-3
-2
-2
-2
-2
-2
EBITDA
-3
-3
-2
-3
-2
-2
-2
-2
-2
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
-
-
Income Before Tax
-3
-3
-2
-3
-2
-2
-2
-2
-2
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-3
-2
-3
-2
-2
-2
-2
-2
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Anixa Biosciences Annual Profit & Loss

All numbers in Millions USD

Oct 2017
Oct 2018
Oct 2019
Oct 2020
Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Total Revenue
0
1
0
-
0
-
0
-
-
Gross Profit
0
0
0
0
0
-
0
0
0
Operating Income
-6
-13
-11
-9
-13
-13
-11
-13
-11
EBITDA
-4
-13
-11
-10
-13
-13
-9
-12
-10
Interest Expense
0
-
-
-
0
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-14
-11
-10
-13
-13
-9
-12
-11
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-5
-13
-11
-10
-12
-13
-9
-12
-10
Net Profit Margin
71.16%
1.69%
33.50%
0.00%
24.80%
0.00%
23.33%
0.00%
0.00%

Anixa Biosciences Quarterly Cash Flow

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Net Income
-3
-3
-2
-3
-2
-2
-2
-2
-2
-2
Operating Cash Flow
-2
-2
0
-2
-1
-1
-1
-2
-1
-1
Investing Cash Flow
2
2
0
2
2
0
0
1
0
0
Financing Cash Flow
0
0
0
0
0
1
0
1
1
1
Change in Cash
0
0
0
0
0
0
0
0
0
0

Anixa Biosciences Annual Cash Flow

All numbers in Millions USD

Oct 2017
Oct 2018
Oct 2019
Oct 2020
Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Net Income
-5
-14
-11
-10
-13
-13
-9
-12
-11
Operating Cash Flow
-3
-4
-4
-6
-4
-6
-6
-7
-7
Investing Cash Flow
-2
1
0
0
-3
-10
-5
4
4
Financing Cash Flow
7
2
5
9
31
0
0
3
2
Change in Cash
0
0
0
2
22
-16
-11
0
0

Global Institutional Holdings in Anixa Biosciences

Check out the Institutions with significant holdings in Anixa Biosciences.

Funds
Holdings
Vanguard
3.71%
VANGUARD INDEX FUNDS
3.67%
Fidelity Concord Street Trust
0.82%
iShares
0.30%
Kenneth Tropin
0.08%

Anixa Biosciences News & Key Events

  • img

    Today's Timeline - 16 September

    Tue, 07:10 PM

    -

    Anixa Biosciences stock has returned 51.7% this year, with EPS estimates rising 7.9% over the past three months.

    Tue, 10:00 PM

    -

    Anixa completes dosing in fourth cohort of Phase 1 ovarian cancer CAR-T trial, showing positive safety profile.

    Tue, 11:35 PM

    -

    Anixa reports improved financial performance, sufficient cash runway, and files US$200 million Shelf Registration for future funding.

Insights on Anixa Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ANIX stock has moved up by 6.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 82.2% return, outperforming this stock by 94.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 576.7%

About Anixa Biosciences

Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within the fields of oncology (cancer) and infectious diseases. Among its therapeutic pipeline, Anixa is developing a novel chimeric endocrine receptor T-cell (CER-T) technology, an innovative adaptation of CAR-T, specifically for ovarian cancer treatment. The company is also engaged in the discovery and development of antiviral drug candidates to combat COVID-19, focusing on the inhibition of specific viral protein functions. On the vaccine front, Anixa's initiatives include a vaccine designed to target triple-negative breast cancer and a distinct preventative vaccine aimed at ovarian cancer. Beyond specific therapies and vaccines, Anixa also has immuno-therapy drugs for various cancers in its development portfolio. A key collaboration exists with MolGenie GmbH for the discovery and development of its COVID-19 antiviral candidates. Tracing its origins back to an incorporation in 1982, the company initially operated as ITUS Corporation before adopting the name Anixa Biosciences, Inc. in October 2018. It is headquartered in San Jose, California.
OrganisationAnixa Biosciences
Headquarters3150 Almaden Expressway, San Jose, CA, 95118, US
IndustryBiotechnology
CEOAmit Kumar

Key Management of Anixa Biosciences

Name

Title

Dr. Pamela D. Garzone Ph.D.

Chief Development Officer & Chair Breast Cancer Clinical Advisory Board

Dr. Amit Kumar Ph.D.

CEO, Chairman & Co-Chair of CBAB

Mr. Michael J. Catelani CPA, MBA

President, COO, CFO & Corporate Secretary

FAQs

What is Anixa Biosciences share price today?

Anixa Biosciences share price today is $2.95 as on at the close of the market. Anixa Biosciences share today touched a day high of $2.93 and a low of $2.77.

What is the 52 week high and 52 week low for Anixa Biosciences share?

Anixa Biosciences share touched a 52 week high of $5.46 on and a 52 week low of $2.32 on . Anixa Biosciences stock price today i.e. is closed at $2.95,which is 45.94% down from its 52 week high and 27.16% up from its 52 week low.

What is Anixa Biosciences's market capitalisation today?

Anixa Biosciences market capitalisation is $0.00T as on .

How to invest in Anixa Biosciences Stock (ANIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Anixa Biosciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Anixa Biosciences Stock (ANIX) from India?

Indian investors can start investing in Anixa Biosciences (ANIX) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Anixa Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Anixa Biosciences share’s latest price of $2.95 as on October 3, 2026 at 8:46 am IST, you will get 3.3898 shares of Anixa Biosciences. Learn more about fractional shares .

What are the returns that Anixa Biosciences has given to Indian investors in the last 5 years?

Anixa Biosciences stock has given -37.89% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?